| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |